Subscribe to Journal
Get full journal access for 1 year
only $41.58 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Treff NR, Eccles J, Lello L, et al. Utility and first clinical application of screening embryos for polygenic disease risk reduction. Front Endocrinol. 2019;10:845.
Treff NR, Eccles J, Marin D, et al. Preimplantation genetic testing for polygenic disease relative risk reduction: evaluation of genomic index performance in 11,883 adult sibling pairs. Genes. 2020;11:648.
Sueoka K. Preimplantation genetic diagnosis: an update on current technologies and ethical considerations. Reprod Med Biol. 2016;15:69–75.
Klitzman R. Challenges, dilemmas and factors involved in PGD decision-making: providers’ and patients’ views, experiences and decisions. J Genet Couns. 2018;27:909–919.
Genoff Garzon MC, Rubin LR, Lobel M, Stelling J, Pastore LM. Review of patient decision-making factors and attitudes regarding preimplantation genetic diagnosis. Clin Genet. 2018;94:22–42.
Ethics Commitee of the American Society for Reproductive Medicine. Use of preimplantation genetic testing for monogenic defects (PGT-M) for adult-onset conditions: an Ethics Committee opinion. Fertil Steril. 2018;109:989–992.
van Rheenen W, Peyrot WJ, Schork AJ, Lee SH, Wray NR. Genetic correlations of polygenic disease traits: from theory to practice. Nat Rev Genet. 2019;20:567–581.
Kumar A, Ryan A, Kitzman JO, et al. Whole genome prediction for preimplantation genetic diagnosis. Genome Med. 2015;7:35.
Khera AV, Chaffin M, Aragam KG, et al. Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations. Nat Genet. 2018;50:1219–1224.
Mostafavi H, Harpak A, Agarwal I, Conley D, Pritchard JK, Przeworski M. Variable prediction accuracy of polygenic scores within an ancestry group. eLife. 2020;9.
Duncan L, Shen H, Gelaye B, et al. Analysis of polygenic risk score usage and performance in diverse human populations. Nat Commun. 2019;10:3328.
Karavani E, Zuk O, Zeevi D, et al. Screening human embryos for polygenic traits has limited utility. Cell. 2019;179:1424–1435.e8.
Schwartz B. The paradox of choice: why more is less. Revised edition. New York: Harper Collins; 2009.
Hadar L, Sood S. When knowledge is demotivating: subjective knowledge and choice overload. Psychol Sci. 2014;25:1739–1747.
Miller PS, Levine RL. Avoiding genetic genocide: understanding good intentions and eugenics in the complex dialogue between the medical and disability communities. Genet Med. 2013;15:95–102.
McCabe LL, McCabe ER. Down syndrome: coercion and eugenics. Genet Med. 2011;13:708–710.
Lombardo PA. The power of heredity and the relevance of eugenic history. Genet Med. 2018;20:1305–1311.
Savulescu J. In defence of procreative beneficence. J Med Ethics. 2007;33:284–288.
The views expressed are those of the authors alone, and do not necessarily reflect views of Baylor College of Medicine, Hebrew University, or Zucker School of Medicine at Hosfstra/Northwell. The authors declare no conflicts of interests.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Lázaro-Muñoz, G., Pereira, S., Carmi, S. et al. Screening embryos for polygenic conditions and traits: ethical considerations for an emerging technology. Genet Med (2020). https://doi.org/10.1038/s41436-020-01019-3